MRC1 and Lynch syndrome: This subset of patients, who generally show a suggestive family pedigree or early-onset tumors with MMR deficiency and no detectable germline mutation or hypermethylation in the MMR genes, are referred to as having Lynch-like syndrome (LLS) [4].